Bristol-Myers Squibb to pay $0.5bn to settle US lawsuitsBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39363.346771.DB (Published 11 October 2007) Cite this as: BMJ 2007;335:742
- Janice Hopkins Tanne
- New York
Bristol-Myers Squibb and its subsidiary Apothecon have agreed to pay more than $515m (£255m; €365m) in a settlement with the US Department of Justice and the Office of the United States Attorney for Massachusetts to resolve allegations involving their drug marketing and pricing practices.
The Department of Justice said in a press release that the “settlement covers a wide assortment of illegal marketing and pricing practices.”
The department said that from about 2000 to mid-2003 Bristol-Myers Squibb made illegal payments to doctors and other healthcare providers to induce them …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial